Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Abdel-Hameed I. Mohammed Ebid"'
Autor:
Abdel-Hameed I. Mohammed Ebid, Ramadan Ahmed Ramadan, Mohamed Ahmed Mobarez, Mohamed Adel Mahmoud
Publikováno v:
Hosp Pharm
Aims: The primary aim of this current study was to investigate the impact of the clinical pharmacist interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes in Egypt. Methods: A prospective trial
Autor:
Sara Hassan Agwa, Abdel-Hameed I. Mohammed Ebid, Osama Ashraf Ahmed, Amira Elsawy, Sara Mohamed Abdel-Motaleb, Radwa Samir Hagag
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 45:539-546
What is known and objective Direct-acting antivirals (DAAs) have become the most widely used treatment of chronic hepatitis C infection. Comparative studies on DAAs regimens approved by the Egyptian Ministry of Health for easy-to-treat genotype 4 (G4
Autor:
Sameh H. Soror, Ashraf Ismail, Abdel-Hameed I. Mohammed Ebid, Moataz Ehab, Mohamed Adel Mahmoud
Publikováno v:
Journal of Drug Assessment. 8:115-121
Background: The incidence of Type 2 Diabetes Mellitus (T2DM) in Egypt is considered one of the highest in the world. Metformin and Sulfonylureas are usually prescribed together due to their efficac...
Publikováno v:
IOSR Journal of Pharmacy and Biological Sciences. 12:40-50
Publikováno v:
British Journal of Pharmaceutical Research. 16:1-14
Publikováno v:
Bulletin of Pharmaceutical Sciences. Assiut. 29:167-185
This work was performed to assess whether a pharmaceutical care program improves outcomes and optimizes quality of life in Egyptian patients with bronchial asthma or chronic obstructive pulmonary disease (COPD). Three hundred and fifty adult patients
Autor:
Mark J. Shelton, Ross G. Hewitt, Robin DiFrancesco, Charles E. Frost, Gene D. Morse, Lawrence J. Gugino, Abdel-Hameed I. Mohammed Ebid, J. Hu, Elizabeth Ingalls, Stephen Cousins, John Clarke Adams
Publikováno v:
Clinical Drug Investigation. 22:125-134
Objective: To characterise the pharmacokinetics of indinavir during different phases of the menstrual cycle in HIV-infected women. Design: Open-label study. Setting: The immunodeficiency clinic at Erie County Medical Center, Buffalo, New York. Patien
Autor:
Lawrence J. Gugino, Mark J. Shelton, Abdel-Hameed I. Mohammed Ebid, Rosemarie Colomaio, Joseph A. Cordaro, Gene D. Morse, John M. Adams, Maureen Maliszewski, Ross G. Hewitt
Publikováno v:
Clinical Drug Investigation. 21:715-726
To examine the pharmacokinetics of zidovudine during each menstrual cycle phase in women with HIV-1 infection. Open-label, nonblinded study. The immunodeficiency clinic at the Erie County Medical Center, Buffalo, New York. 12 HIV-seropositive women s
Publikováno v:
Therapeutic drug monitoring. 29(3)
This work was performed to explore the effect of polymorphism in multidrug resistant genes on plasma phenytoin levels and patient outcome to evaluate its involvement in drug resistance and toxicity, which is usually associated with antiepileptic drug
Publikováno v:
Therapeutic drug monitoring. 23(3)
This work was performed to study the pharmacokinetics of phenobarbital during renal clearance enhancement, intestinal clearance enhancement, and a combination of both to determine which method is clinically more effective in the management of drug po